MOLECULAR AND CELL BIOLOGY OF CD36 A TSP RECEPTOR
MOLECULAR AND CELL BIOLOGY OF CD36 A TSP RECEPTOR
批准号:
2028458
负责人:
Roy L Silverstein
金额:
$23.79万
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 2001-07-31
关键词:
CD antigens RNase protection assay atherosclerotic plaque chimeric proteins genetic models genetically modified animals immunocytochemistry intermolecular interaction laboratory mouse laboratory rabbit ligands low density lipoprotein low density lipoprotein receptor macrophage membrane proteins model design /development monocyte protein structure function receptor receptor binding receptor expression thrombospondins
中文摘要
点击翻译按钮获取中文摘要
英文摘要
CD36 is a multifunctional 88kD transmembrane glycoprotein
expressed on platelets, monocytes, macrophages, certain specialized
epithelial cells, and adipocytes. It has been shown to function as a
cellular receptor for thrombospondin (TSP) and has recently been
implicated as a macrophage scavenger receptor for oxidized low
density lipoprotein (OxLDL). Oxidation of LDL is strongly linked to
the pathogenesis of atherosclerosis in that lipid accumulation in
atheromatous plaque results directly from internalization of OxLDL by
intimal macrophages. In addition, OxLDL interactions with vascular
cells may result in cellular activation to a prothrombotic,
proatherogenic phenotype. The central hypothesis of this proposal is
that CD36 is a major macrophage receptor for binding and
internalizing ligands, including TSP and OxLDL. The focus will be to
define the molecular basis of CD36 function and to probe its role in
atherosclerosis. Studies in specific aim l will define structure-function
relationships that govern CD36 receptor-ligand binding. Interactions
with TSP and Oxidized LDL will be studies. These experiments will
utilize recombinant CD36 peptides and solid phase and cellular binding
studies. Specific aim 2 will define the mechanisms by which human
macrophage CD36 internalizes ligands. Regulation of macrophage
CD36 mRNA synthesis and surface protein expression in response to
mediators of atherogenesis and differentiation will be studied using
RNAse protection assays and immunomicroscopy. CD36-mediated
internalization pathways and structure-function relationships that
govern internalization will also be probed. Aim 3 will evaluate the role
of CD36 in monocyte/macrophage biology by developing and studying
a murine model genetically engineered so as not to express CD36.
Completion of this project will increase understanding of early
atherogenic events and allow for the development of novel therapeutic
strategies by specific blockade of OxLDL-macrophage interactions.
Furthermore, understanding how internalization and intracellular
signaling is accomplished by CD36 may lead to broader insight into
cellular function. The animal model may also be useful in testing the
role of oxidants and anti-oxidants in atherogenesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanistic Role of CD36 in Thrombosis
-
批准号:8850653
-
项目类别:
-
资助金额:$4.52万
-
财政年份:2013
-
负责人:Roy L Silverstein
-
依托单位:
Mechanistic Role of CD36 in Thrombosis
-
批准号:8509398
-
项目类别:
-
资助金额:$36.89万
-
财政年份:2013
-
负责人:Roy L Silverstein
-
依托单位:
Mechanistic Role of CD36 in Thrombosis
-
批准号:9068225
-
项目类别:
-
资助金额:$43.0万
-
财政年份:2013
-
负责人:Roy L Silverstein
-
依托单位:
Mechanistic Role of CD36 in Thrombosis
-
批准号:8856644
-
项目类别:
-
资助金额:$42.23万
-
财政年份:2013
-
负责人:Roy L Silverstein
-
依托单位:
Regulation of the anti-angiogenic switch by CD36, Thrombospondin, and HRGP
-
批准号:7524585
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2008
-
负责人:Roy L Silverstein
-
依托单位:
Regulation of the anti-antiangiogenic switch by CD36, Thrombospondin, and HRGP
-
批准号:7642363
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2008
-
负责人:Roy L Silverstein
-
依托单位:
Regulation of the anti-antiangiogenic switch by CD36, Thrombospondin, and HRGP
-
批准号:8269065
-
项目类别:
-
资助金额:$38.83万
-
财政年份:2008
-
负责人:Roy L Silverstein
-
依托单位:
Regulation of the anti-antiangiogenic switch by CD36, Thrombospondin, and HRGP
-
批准号:7858475
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2008
-
负责人:Roy L Silverstein
-
依托单位:
INFLAMMATORY CELL SIGNALING BY CD36
-
批准号:7337249
-
项目类别:
-
资助金额:$39.92万
-
财政年份:2007
-
负责人:Roy L Silverstein
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7337250
-
项目类别:
-
资助金额:$13.96万
-
财政年份:2007
-
负责人:Roy L Silverstein
-
依托单位:
Oxidized Phospholipids in Vascular Pathobiology
-
批准号:7615095
-
项目类别:
-
资助金额:$228.17万
-
财政年份:2007
-
负责人:Roy L Silverstein
-
依托单位:
Oxidized Phospholipids in Vascular Pathobiology
-
批准号:7297503
-
项目类别:
-
资助金额:$232.34万
-
财政年份:2007
-
负责人:Roy L Silverstein
-
依托单位:
Candidate Genes Affecting Adolescent Metabolic Syndrome
-
批准号:8100165
-
项目类别:
-
资助金额:$57.07万
-
财政年份:2007
-
负责人:Roy L Silverstein
-
依托单位:
Oxidized Phospholipids in Vascular Pathobiology
-
批准号:7479739
-
项目类别:
-
资助金额:$228.21万
-
财政年份:2007
-
负责人:Roy L Silverstein
-
依托单位:
ROLE OF CD 36 AS PRO-THROMBOTIC PLATELET SURFACE RECEPTOR
-
批准号:7493846
-
项目类别:
-
资助金额:$37.21万
-
财政年份:2007
-
负责人:Roy L Silverstein
-
依托单位:
Oxidized Phospholipids in Vascular Pathobiology
-
批准号:7841709
-
项目类别:
-
资助金额:$228.12万
-
财政年份:2007
-
负责人:Roy L Silverstein
-
依托单位:
Genetic and Cellular Determinants of Arterial Thrombosis
-
批准号:7212067
-
项目类别:
-
资助金额:$252.04万
-
财政年份:2006
-
负责人:Roy L Silverstein
-
依托单位:
ROLE OF CD 36 AS PRO-THROMBOTIC PLATELET SURFACE RECEPTOR
-
批准号:7226375
-
项目类别:
-
资助金额:$36.06万
-
财政年份:2006
-
负责人:Roy L Silverstein
-
依托单位:
Genetic and Cellular Determinants of Arterial Thrombosis
-
批准号:7408541
-
项目类别:
-
资助金额:$252.36万
-
财政年份:2006
-
负责人:Roy L Silverstein
-
依托单位:
Genetic and Cellular Determinants of Arterial Thrombosis
-
批准号:7615053
-
项目类别:
-
资助金额:$263.68万
-
财政年份:2006
-
负责人:Roy L Silverstein
-
依托单位:
海外基金